Medtronic (MDT) Cost of Revenue (2014 - 2026)

Medtronic has disclosed Cost of Revenue across 13 years of filings, most recently posting $3.4 billion for Q3 2026.

• In Q3 2026, Cost of Revenue rose 13.83% year-over-year to $3.4 billion; the TTM figure through Jul 2026 stood at $13.1 billion (up 10.64% YoY), while the FY2026 annual figure was $12.7 billion, up 9.36% from the prior year.
• Cost of Revenue came in at $3.4 billion for Q3 2026 at Medtronic, up from $3.4 billion in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $3.4 billion in Q3 2026 to a low of $2.5 billion in Q1 2022.
• Average Cost of Revenue over 5 years is $2.9 billion, with a median of $2.8 billion recorded in 2024.
• Year-over-year, Cost of Revenue declined 6.18% in 2022 and grew 17.34% in 2026.
• Over 5 years, Cost of Revenue stood at $2.5 billion in 2022, then rose by 8.92% to $2.8 billion in 2023, then climbed by 6.7% to $2.9 billion in 2024, then gained by 3.9% to $3.1 billion in 2025, then rose by 11.6% to $3.4 billion in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $3.4 billion in Q3 2026, $3.4 billion in Q2 2026, and $3.3 billion in Q1 2026.